Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sunita , Yogendra Singh, Gillian Beamer, Xingmin Sun & Pratyoosh Shukla. (2022) Recent developments in systems biology and genetic engineering toward design of vaccines for TB. Critical Reviews in Biotechnology 42:4, pages 532-547.
Read now
Read now
Federico Martinón-Torres, Adolfo García-Sastre, Andrew J. Pollard, Carlos Martín, Albert Osterhaus, Shamez N Ladhani, Octavio Ramilo, Jose Gómez Rial, Antonio Salas, F Xavier Bosch, María Martinón-Torres, Michael J. Mina & James Cherry. (2021) TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO). Human Vaccines & Immunotherapeutics 17:11, pages 4299-4327.
Read now
Read now
Articles from other publishers (35)
Sergio Lacámara & Carlos Martin. (2023) MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention. Archivos de Bronconeumología 59:12, pages 821-828.
Crossref
Crossref
Li Zhuang, Zhaoyang Ye, Linsheng Li, Ling Yang & Wenping Gong. (2023) Next-Generation TB Vaccines: Progress, Challenges, and Prospects. Vaccines 11:8, pages 1304.
Crossref
Crossref
Elsa Anes, David Pires, Manoj Mandal & José Miguel Azevedo-Pereira. (2023) ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis. Biomolecules 13:6, pages 968.
Crossref
Crossref
Ifeanyi Elibe Mba, Hyelnaya Cletus Sharndama, Zikora Kizito Glory Anyaegbunam, Chijioke Chinedu Anekpo, Ben Chibuzo Amadi, Daji Morumda, Yandev Doowuese, Uchechi Justina Ihezuo, Joseph Ukomadu Chukwukelu & Onyekachi Philomena Okeke. (2023) Vaccine development for bacterial pathogens: Advances, challenges and prospects. Tropical Medicine & International Health 28:4, pages 275-299.
Crossref
Crossref
Bhupendra Singh Rawat, Deepak Kumar, Vijay Soni & Eric H. Rosenn. (2022) Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination. Vaccines 10:12, pages 2127.
Crossref
Crossref
Aregitu Mekuriaw Arega, Ajit Kumar Dhal, Sasmita Nayak & Rajani Kanta Mahapatra. (2022) In silico and in vitro study of Mycobacterium tuberculosis H37Rv uncharacterized protein (RipD): an insight on tuberculosis therapeutics. Journal of Molecular Modeling 28:6.
Crossref
Crossref
Sirwan Zare, Mona Kabiri, Yousef Amini, Adel Najafi, Fatemeh Mohammadpour, Seyed Hasan Ayati, Amin Reza Nikpoor & Mohsen Tafaghodi. (2021) Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis. AAPS PharmSciTech 23:1.
Crossref
Crossref
Carlos Martín, Dessislava Marinova, Nacho Aguiló & Jesús Gonzalo-Asensio. (2021) MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG. Vaccine 39:50, pages 7277-7285.
Crossref
Crossref
Esther Broset, Jacobo Pardo-Seco, Alex I. Kanno, Nacho Aguilo, Ana Isabel Dacosta, Irene Rivero-Calle, Jesus Gonzalo-Asensio, Camille Locht, Luciana C.C. Leite, Carlos Martin & Federico Martinón-Torres. (2021) BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies. EBioMedicine 65, pages 103254.
Crossref
Crossref
Raquel Tarancón, Elena Mata, Santiago Uranga, Ana Belén Gómez, Dessislava Marinova, Isabel Otal, Carlos Martín & Nacho Aguiló. (2021) Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environment. EBioMedicine 64, pages 103186.
Crossref
Crossref
Michel P.M. Vierboom, Karin Dijkman, Claudia C. Sombroek, Sam O. Hofman, Charelle Boot, Richard A.W. Vervenne, Krista G. Haanstra, Maarten van der Sande, Liesbeth van Emst, Jorge Domínguez-Andrés, Simone J.C.F.M. Moorlag, Clemens H.M. Kocken, Jelle Thole, Esteban Rodríguez, Eugenia Puentes, Joost H.A. Martens, Reinout van Crevel, Mihai G. Netea, Nacho Aguilo, Carlos Martin & Frank A.W. Verreck. (2021) Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Reports Medicine 2:1, pages 100185.
Crossref
Crossref
Laylaa Ramos, Joan K. Lunney & Mercedes Gonzalez-Juarrero. (2020) Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models. Disease Models & Mechanisms 13:9.
Crossref
Crossref
Anni K. Saralahti, Meri I. E. Uusi-Mäkelä, Mirja T. Niskanen & Mika Rämet. (2020) Integrating fish models in tuberculosis vaccine development. Disease Models & Mechanisms 13:8.
Crossref
Crossref
Junli Li, Aihua Zhao, Jun Tang, Guozhi Wang, Yanan Shi, Lingjun Zhan & Chuan Qin. (2020) Tuberculosis vaccine development: from classic to clinical candidates. European Journal of Clinical Microbiology & Infectious Diseases 39:8, pages 1405-1425.
Crossref
Crossref
Nacho Aguilo, Santiago Uranga, Elena Mata, Raquel Tarancon, Ana Belén Gómez, Dessislava Marinova, Isabel Otal, Marta Monzón, Juan Badiola, Dolores Montenegro, Eugenia Puentes, Esteban Rodríguez, Richard A. W. Vervenne, Claudia C. Sombroek, Frank A. W. Verreck & Carlos Martín. (2020) Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates. Frontiers in Microbiology 11.
Crossref
Crossref
Irene Pérez, Santiago Uranga, Fadel Sayes, Wafa Frigui, Sofía Samper, Ainhoa Arbués, Nacho Aguiló, Roland Brosch, Carlos Martín & Jesús Gonzalo-Asensio. (2020) Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential. EBioMedicine 55, pages 102761.
Crossref
Crossref
Carlos Martin, Nacho Aguilo, Dessislava Marinova & Jesus Gonzalo-Asensio. (2020) Update on TB Vaccine Pipeline. Applied Sciences 10:7, pages 2632.
Crossref
Crossref
Sangeeta Tiwari, Rosalyn Casey, Celia W. Goulding, Suzie Hingley-Wilson & William R. JacobsJrJr. 2019. Bacteria and Intracellularity. Bacteria and Intracellularity
113
126
.
Iratxe Díez-Delgado, Iker A. Sevilla, Joseba M. Garrido, Beatriz Romero, María V. Geijo, Lucas Dominguez, Ramón A. Juste, Alicia Aranaz, José de la Fuente & Christian Gortazar. (2019) Tuberculosis vaccination sequence effect on protection in wild boar. Comparative Immunology, Microbiology and Infectious Diseases 66, pages 101329.
Crossref
Crossref
Farzam Vaziri & Roland Brosch. 2019. Protein Secretion in Bacteria. Protein Secretion in Bacteria
351
362
.
Helen McShane. (2019) Insights and challenges in tuberculosis vaccine development. The Lancet Respiratory Medicine 7:9, pages 810-819.
Crossref
Crossref
Patricia Méndez‐Samperio. (2019) Novel vaccination strategies and approaches against human tuberculosis. Scandinavian Journal of Immunology 90:2.
Crossref
Crossref
Farzam Vaziri & Roland Brosch. (2019) ESX/Type VII Secretion Systems—An Important Way Out for Mycobacterial Proteins. Microbiology Spectrum 7:4.
Crossref
Crossref
Sangeeta Tiwari, Rosalyn Casey, Celia W. Goulding, Suzie Hingley-Wilson & William R. Jacobs, Jr.Jr.Jr.. (2019)
Infect and Inject: How
Mycobacterium tuberculosis
Exploits Its Major Virulence-Associated Type VII Secretion System, ESX-1
. Microbiology Spectrum 7:3.
Crossref
Crossref
Jesus Gonzalo-asensio, Nacho Aguilo, Dessislava Marinova & Carlos Martin. 2019. Microbial Transmission. Microbial Transmission
249
261
.
Vera M. Kroesen, Jan Madacki, Wafa Frigui, Fadel Sayes & Roland Brosch. (2019) Mycobacterial virulence: impact on immunogenicity and vaccine research. F1000Research 8, pages 2025.
Crossref
Crossref
Morten Ruhwald, Peter L. Andersen & Lewis Schrager. 2018. Tuberculosis. Tuberculosis
343
363
.
Saeed Khoshnood, Mohsen Heidary, Mehri Haeili, Michel Drancourt, Davood Darban-Sarokhalil, Mohammad Javad Nasiri & Vahid Lohrasbi. (2018) Novel vaccine candidates against Mycobacterium tuberculosis. International Journal of Biological Macromolecules 120, pages 180-188.
Crossref
Crossref
Carlos Martin, Nacho Aguilo & Jesús Gonzalo-Asensio. (2018) Vaccination against tuberculosis. Enfermedades infecciosas y microbiologia clinica (English ed.) 36:10, pages 648-656.
Crossref
Crossref
Carlos Martin, Nacho Aguilo & Jesús Gonzalo-Asensio. (2018) Vacunación frente a tuberculosis. Enfermedades Infecciosas y Microbiología Clínica 36:10, pages 648-656.
Crossref
Crossref
Samuel Alvarez-Arguedas, Santiago Uranga, Manuel Martín, Javier Elizalde, Ana Belen Gomez, Esther Julián, Denise Nardelli-Haefliger, Carlos Martín & Nacho Aguilo. (2018) Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer. Translational Research 197, pages 32-42.
Crossref
Crossref
Hazel M. Dockrell. 2018. The Value of BCG and TNF in Autoimmunity. The Value of BCG and TNF in Autoimmunity
57
70
.
Jesus Gonzalo-Asensio, Dessislava Marinova, Carlos Martin & Nacho Aguilo. (2017) MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic. Frontiers in Immunology 8.
Crossref
Crossref
Christophe J. Queval, Roland Brosch & Roxane Simeone. (2017) The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis. Frontiers in Microbiology 8.
Crossref
Crossref
Jesus Gonzalo-Asensio, Nacho Aguilo, Dessislava Marinova & Carlos Martin. (2017) Breaking Transmission with Vaccines: The Case of Tuberculosis. Microbiology Spectrum 5:4.
Crossref
Crossref